Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Controlled Trial ◽

Gram Negative Bacteria ◽

Open Label ◽

Gram Negative ◽

Carbapenem Resistant ◽

Severe Infections ◽

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

BMJ Open ◽

10.1136/bmjopen-2015-009956 ◽

2016 ◽

Vol 6 (4) ◽

pp. e009956 ◽

Cited By ~ 25

Author(s):

Yaakov Dickstein ◽

Leonard Leibovici ◽

Dafna Yahav ◽

Noa Eliakim-Raz ◽

George L Daikos ◽

...

Keyword(s):

Study Protocol ◽

Controlled Trial ◽

Open Label ◽

Gram Negative ◽

Carbapenem Resistant ◽

Severe Infections ◽

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12032956.13172054 ◽

2011 ◽

Author(s):

Carlos Seas ◽

Jorge Alave

Keyword(s):

Enteric Fever ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13368964.14739064 ◽

2011 ◽

Author(s):

Vineet Bhandari

Keyword(s):

Mechanical Ventilation ◽

Preterm Infants ◽

Controlled Trial ◽

Open Label ◽

Surfactant Treatment ◽

Randomised Controlled ◽

Spontaneously Breathing

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

D2 Gastrectomy ◽

Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548124.793152981 ◽

2012 ◽

Author(s):

Mitesh Borad

Keyword(s):

Minimally Invasive ◽

Oesophageal Cancer ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548124.793003137 ◽

2012 ◽

Author(s):

Tim Underwood

Keyword(s):

Minimally Invasive ◽

Oesophageal Cancer ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995519.793476076 ◽

2013 ◽

Author(s):

Kellie Mathis

Keyword(s):

Controlled Trial ◽

Intraepithelial Neoplasia ◽

Anal Intraepithelial Neoplasia ◽

Hiv Positive ◽

Open Label ◽

Sex With Men ◽

Randomised Controlled ◽

Hiv Positive Men

Faculty Opinions recommendation of Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718061912.793482586 ◽

2013 ◽

Author(s):

Jane Norman

Keyword(s):

Preterm Birth ◽

Controlled Trial ◽

Multiple Pregnancy ◽

Open Label ◽

Faculty Opinions recommendation of 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718043513.793482079 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Controlled Trial ◽

Her2 Positive ◽

Open Label ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Randomised Controlled ◽

Positive Breast Cancer